相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predicting CYP3A-mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure
Janneke M. Brussee et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Jugular and Portal Vein Volume, Middle Cerebral Vein Velocity, and Intracranial Pressure in Dry Immersion
Philippe Arbeille et al.
AEROSPACE MEDICINE AND HUMAN PERFORMANCE (2017)
Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children
Nienke J. Vet et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Literature Review of Gastrointestinal Physiology in the Elderly, in Pediatric Patients, and in Patients with Gastrointestinal Diseases
Jane P. F. Bai et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Semiphysiologically Based Pharmacokinetic Model for Midazolam and CYP3A Mediated Metabolite 1-OH-Midazolam in Morbidly Obese and Weight Loss Surgery Patients
M. J. E. Brill et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
Population Pharmacokinetic Model Characterizing 24-Hour Variation in the Pharmacokinetics of Oral and Intravenous Midazolam in Healthy Volunteers
A. van Rongen et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2015)
A mechanistic approach to understanding oral drug absorption in pediatrics: an overview of fundamentals
Nir Debotton et al.
DRUG DISCOVERY TODAY (2014)
A Workflow Example of PBPK Modeling to Support Pediatric Research and Development: Case Study with Lorazepam
A. R. Maharaj et al.
AAPS JOURNAL (2013)
A Semiphysiological Population Pharmacokinetic Model for Dynamic Inhibition of Liver and Gut Wall Cytochrome P450 3A by Voriconazole
Sebastian Frechen et al.
CLINICAL PHARMACOKINETICS (2013)
Assessing circadian rhythms during prolonged midazolam infusion in the pediatric intensive care unit (PICU) children
Agnieszka Bienert et al.
PHARMACOLOGICAL REPORTS (2013)
Ontogeny of oral drug absorption processes in children
Miriam G. Mooij et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Acute kidney injury reduces the hepatic metabolism of midazolam in critically ill patients
C. J. Kirwan et al.
INTENSIVE CARE MEDICINE (2012)
How important is intestinal cytochrome P450 3A metabolism?
Antonius E. van Herwaarden et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Pharmacokinetics and clinical efficacy of midazolam in children with severe malaria and convulsions
Simon N. Muchohi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models:: The npde add-on package for R
Emmanuelle Comets et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2008)
Prediction of intestinal first-pass drug metabolism
Jiansong Yang et al.
CURRENT DRUG METABOLISM (2007)
Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data:: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver
Zoe E. Barter et al.
CURRENT DRUG METABOLISM (2007)
Pharmacokinetics and pharmacodynamics of midazolam and metabolites in nonventilated infants after craniofacial surgery
Mariska Y. M. Peeters et al.
ANESTHESIOLOGY (2006)
The human intestinal cytochrome P450 pie
MF Paine et al.
DRUG METABOLISM AND DISPOSITION (2006)
Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children
Trevor N. Johnson et al.
CLINICAL PHARMACOKINETICS (2006)
Changes in liver volume from birth to adulthood: A meta-analysis
TN Johnson et al.
LIVER TRANSPLANTATION (2005)
Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling:: theophylline and midazolam as model drugs
S Björkman
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
The effects of dose staggering on metabolic drug-drug interactions
JS Yang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes
K Ito et al.
DRUG METABOLISM AND DISPOSITION (2003)
Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients
SN de Wildt et al.
CRITICAL CARE MEDICINE (2003)
Oxidative metabolism of amprenavir in the human liver.: Effect of the CYP3A maturation
JM Tréluyer et al.
DRUG METABOLISM AND DISPOSITION (2003)
Developmental expression of the major human hepatic CYP3A enzymes
JC Stevens et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping
JI Lee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
The cytochrome P450 superfamily: Biochemistry, evolution and drug metabolism in humans
PB Danielson
CURRENT DRUG METABOLISM (2002)
The ontogeny of human drug-metabolizing enzymes: Phase I oxidative enzymes
RN Hines et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
The single-dose pharmacokinetics of midazolam and its primary metabolite in pediatric patients after oral and intravenous administration
MD Reed et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Characterization of age-related changes in body weight and organ weights from birth to adolescence in humans
S Haddad et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A (2001)
Ways to fit a PK model with some data below the quantification limit
SL Beal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis
TN Johnson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
分享论文
